Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

2009/11/12 by James A Bonner, James A. Bonner, Paul M Harari +20 · 14 citations
Medicine · #Esophageal Cancer Research and Treatment #Head and Neck Cancer Studies #Salivary Gland Tumors Diagnosis and Treatment

paper · doi:10.1016/s1470-2045(09)70311-0

openalex publication_date 2009/11/12 · crossref created 2009/11/12 · crossref issued 2010/01/01 · crossref published 2010/01/01 · crossref published-print 2010/01/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/26 · crossref indexed 2026/06/10 · openalex updated_date 2026/07/29

Cited by

• The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer
• Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
• E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
• HPV-Associated Head and Neck Cancer
• The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
• Treatment Deintensification Strategies for HPV-Associated Head and Neck Carcinomas
• Maximizing survival and minimizing toxicity
• De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis of current clinical trials
• Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline
• Considerations in surgical versus non-surgical management of HPV positive oropharyngeal cancer
• Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma
• Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia
• Current Status and Future Directions of Treatment Deintensification in Human Papilloma Virus-associated Oropharyngeal Squamous Cell Carcinoma
• HPV-positive oropharyngeal cancer [wikipedia]